MyFinsight
Home
Blog
About
Proceeds from
redemptions/sales of short-term...
$2,038M
(-68.86%↓ Y/Y)
Proceeds from sale of
investment-Viiv Healthcare...
$1,875M
Asset write-offs and
impairments
$4,393M
(2752.60%↑ Y/Y)
Net (purchases
of)/proceeds from...
-$1,178M
(0.51%↑ Y/Y)
Proceeds from
redemptions/sales of long-term...
$84M
(33.33%↑ Y/Y)
Purchases of long-term
investments
-$9M
(81.25%↑ Y/Y)
Depreciation and
amortization
$1,622M
(-0.18%↓ Y/Y)
Share-based compensation
expense
$249M
(22.66%↑ Y/Y)
Net cash provided
by/(used in) investing...
$2,106M
(-46.70%↓ Y/Y)
Net cash provided
by/(used in) operating...
$835M
(243.47%↑ Y/Y)
Canceled cashflow
$3,078M
Canceled cashflow
$5,430M
Net
increase/(decrease) in cash and cash...
-$727M
(-441.31%↓ Y/Y)
Canceled cashflow
$2,941M
Net (payments
on)/proceeds from short-term...
$64M
(112.38%↑ Y/Y)
Purchases of short-term
investments
$2,544M
(-22.01%↓ Y/Y)
Purchases of property,
plant and equipment
$533M
(-13.75%↓ Y/Y)
Other investing
activities, net
$1M
(-91.67%↓ Y/Y)
Net gain from the
sale of investment in...
$1,870M
Other changes in
assets and...
$1,816M
(-63.60%↓ Y/Y)
Deferred taxes
-$1,320M
(-385.29%↓ Y/Y)
Net income from
continuing operations...
-$246M
(-108.47%↓ Y/Y)
Benefit plan
contributions in excess of...
$112M
(6.67%↑ Y/Y)
Other adjustments,
net
$66M
(-34.65%↓ Y/Y)
Net cash provided
by/(used in) financing...
-$3,663M
(-14.61%↓ Y/Y)
Canceled cashflow
$64M
Effect of
exchange-rate changes on cash...
-$4M
(-109.76%↓ Y/Y)
Cash dividends paid
$2,451M
(0.25%↑ Y/Y)
Payments on long-term
debt
$1,250M
(-66.67%↓ Y/Y)
Other financing
activities, net
-$27M
(-28.57%↓ Y/Y)
Back
Back
Cash Flow
Pfizer_(2021)-svg
PFIZER INC (PFE)
Pfizer_(2021)-svg
PFIZER INC (PFE)
source: myfinsight.com